Literature DB >> 6305894

Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation.

A Barrett, M H Depledge, R L Powles.   

Abstract

Idiopathic and infective interstitial pneumonitis (IPn) is a common complication after bone marrow transplantation (BMT) in many centers and carries a high mortality. We report here a series of 107 patients with acute leukemia grafted at the Royal Marsden Hospital in which only 11 (10.3%) developed IPn and only 5 died (5%). Only one case of idiopathic IPn was seen. Factors which may account for this low incidence are discussed. Sixty of 107 patients were transplanted in first remission of acute myeloid leukemia (AML) and were therefore in good general condition. Lung radiation doses were carefully monitored and doses of 10.5 Gy were not exceeded except in a group of 16 patients in whom a study of escalating doses of TBI (up to 13 Gy) was undertaken. The dose rate used for total body irradiation (TBI) was lower than that used in other centers and as demonstrated elsewhere by ourselves and others, reduction of dose rate to less than 0.05 Gy/min may be expected to lead to substantial reduction in lung damage. Threshold doses of approximately 8 Gy for IPn have been reported, but within the dose range of 8 to 10.5 Gy we suggest that dose rate may significantly affect the incidence. Data so far available suggest a true improvement in therapeutic ratio for low dose rate single fraction TBI compared with high dose rate.

Entities:  

Mesh:

Year:  1983        PMID: 6305894     DOI: 10.1016/0360-3016(83)90393-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group.

Authors:  Natia Esiashvili; Xiaomin Lu; Ken Ulin; Fran Laurie; Sandy Kessel; John A Kalapurakal; Thomas E Merchant; David S Followill; Vythialinga Sathiaseelan; Mary K Schmitter; Meenakshi Devidas; Yichen Chen; Donna A Wall; Patrick A Brown; Stephen P Hunger; Stephan A Grupp; Michael A Pulsipher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-23       Impact factor: 7.038

2.  Allogeneic and autologous bone-marrow transplantation.

Authors:  H J Deeg
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

Review 3.  Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems.

Authors:  Nicholas Dainiak; Robert Nicolas Gent; Zhanat Carr; Rita Schneider; Judith Bader; Elena Buglova; Nelson Chao; C Norman Coleman; Arnold Ganser; Claude Gorin; Martin Hauer-Jensen; L Andrew Huff; Patricia Lillis-Hearne; Kazuhiko Maekawa; Jeffrey Nemhauser; Ray Powles; Holger Schünemann; Alla Shapiro; Leif Stenke; Nelson Valverde; David Weinstock; Douglas White; Joseph Albanese; Viktor Meineke
Journal:  Disaster Med Public Health Prep       Date:  2011-10-10       Impact factor: 1.385

Review 4.  Bone marrow transplantation and the lung.

Authors:  P J Hamilton; A D Pearson
Journal:  Thorax       Date:  1986-07       Impact factor: 9.139

5.  Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma.

Authors:  K Nysom; K Holm; B Hesse; C S Ulrik; N Jacobsen; H Bisgaard; H Hertz
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

6.  Total body irradiation (TBI) in pediatric patients. A single-center experience after 30 years of low-dose rate irradiation.

Authors:  Claudia Linsenmeier; Daniel Thoennessen; Laura Negretti; Jean-Pierre Bourquin; Tino Streller; Urs Martin Lütolf; Susanne Oertel
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

7.  Can lung function measurements be used to predict which patients will be at risk of developing interstitial pneumonitis after bone marrow transplantation?

Authors:  H J Milburn; H G Prentice; R M du Bois
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

8.  Chemotherapy-radiation interactions in human cervix carcinoma xenografts.

Authors:  K S Tonkin; L R Kelland; G G Steel
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

9.  Pulmonary Toxicity after Total Body Irradiation-An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical Data.

Authors:  Michael Oertel; Christopher Kittel; Jonas Martel; Jan-Henrik Mikesch; Marco Glashoerster; Matthias Stelljes; Hans Theodor Eich
Journal:  Cancers (Basel)       Date:  2021-06-12       Impact factor: 6.639

10.  Total body irradiation and pneumonitis risk: a review of outcomes.

Authors:  S A Carruthers; M M Wallington
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.